Search alternatives:
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
12301
-
12302
-
12303
-
12304
-
12305
-
12306
-
12307
-
12308
-
12309
-
12310
HDAC and proteasome inhibition leads to apoptosis via pro-apoptosis protein activation, ROS production and caspase activation.
Published 2017“…(D) The low-dose quisinostat/bortezomib drug combination brings about a significant decrease in the viability of primary synovial sarcoma cells (83-SS) as compared to matched normal muscle cells derived from the same patient (83-muscle). …”
-
12311
hMSC adjunctive therapy failed to decrease pulmonary inflammation or prevent ALI compared to antiviral therapy alone in experimental severe influenza.
Published 2013“…<p>Eight-week old male C57Bl/6 mice infected with 425 EID<sub>50</sub> influenza A/PR/8 virus were administered 2.5 mg/kg oseltamivir in 100 ul ddH2O via gavage, 1×daily for 5 days, beginning day 2 P.I., with or without hMSC administration (5×10<sup>5</sup> cells) on day 2 P.I. and sacrificed on day 7 P.I. …”
-
12312
A Hierarchical Contact–Electrification Interface Based on Gradient Micro-/Nanostructured Hydrogel for Cardiovascular Disease Monitoring
Published 2025“…Importantly, a preliminary 10 day blood pressure test on 22 volunteers showed an error margin of less than ±5 mm Hg, demonstrating its potential as a cardiovascular health product.…”
-
12313
A Hierarchical Contact–Electrification Interface Based on Gradient Micro-/Nanostructured Hydrogel for Cardiovascular Disease Monitoring
Published 2025“…Importantly, a preliminary 10 day blood pressure test on 22 volunteers showed an error margin of less than ±5 mm Hg, demonstrating its potential as a cardiovascular health product.…”
-
12314
-
12315
AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves.
Published 2025Subjects: -
12316
-
12317
The details of terminal deoxynulceotidyl transferase nick-end-labeling (TUNEL) staining.
Published 2023Subjects: -
12318
Result of terminal deoxynulceotidyl transferase nick-end-labeling (TUNEL) staining.
Published 2023Subjects: -
12319
-
12320